Literature DB >> 19710595

Acute hepatitis C in HIV-infected patients: rare spontaneous clearance correlates with weak memory CD4 T-cell responses to hepatitis C virus.

Aurélie Schnuriger1, Stéphanie Dominguez, Marguerite Guiguet, Sawsan Harfouch, Assia Samri, Zineb Ouazene, Laurence Slama, Anne Simon, Marc-Antoine Valantin, Vincent Thibault, Brigitte Autran.   

Abstract

OBJECTIVES: To explore the parameters of specific immunity to hepatitis C virus (HCV) associated with virus clearance during acute HCV infection in HIV coinfection.
METHODS: HIV-infected patients without prior HCV infection were prospectively enrolled for acute hepatitis C and followed up over 15 months. HCV-specific T cells were assessed by proliferation, ELISpot, intracellular cytokine staining and pentamer assays. Pegylated-interferon-alpha and ribavirin were proposed if HCV persisted at M3.
RESULTS: Thirty eight acutely HCV-infected HIV-positive patients were enrolled. HCV genotypes were predominantly 4 and 1. Five patients (13%) showed spontaneous clearance and 20 initiated treatment, of whom 13 (65%) showed sustained virologic responses. Before M3, HCV-specific proliferative responses observed in 35% cases, were associated with lower HCV viral load (P = 0.04) and predictive of spontaneous clearance (P = 0.02), particularly anti-NS4 responses (P = 0.03). These HCV-specific proliferative responses were associated with HIV-p24-specific responses (P = 0.002) independently from the HIV stage. Interferon-gamma-producing T cells specific for HCV were detectable ex vivo in 81% cases but at low intensity (<150 spot forming cells/10 peripheral blood mononuclear cells) and were independent of the HCV outcome. Low frequencies of pentamer-positive HCV-specific CD8 cells (0.01-0.05%) detected in nine of 12 patients were mainly effector-memory PD-1-negative T cells. Twelve days of HCV-specific in-vitro culture induced amplification of CD4 T cells coproducing interleukin-2 and interferon-gamma but rarely of CD8 T cells.
CONCLUSION: Acute HCV infection in HIV-coinfected patients is characterized by a low rate of spontaneous clearance and weak HCV-specific memory T cells, not strictly related to HIV-induced immune defects, and which correlate with virus clearance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19710595     DOI: 10.1097/QAD.0b013e328330ed24

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  22 in total

Review 1.  Treatment of acute HCV infection.

Authors:  Jason Grebely; Gail V Matthews; Gregory J Dore
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-03-22       Impact factor: 46.802

2.  Transmission and evolution of hepatitis C virus in HCV seroconverters in HIV infected subjects.

Authors:  Chengli Shen; Phalguni Gupta; Xiaochuan Xu; Anwesha Sanyal; Charles Rinaldo; Eric Seaberg; Joseph B Margolick; Otoniel Martinez-Maza; Yue Chen
Journal:  Virology       Date:  2013-12-22       Impact factor: 3.616

3.  Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men.

Authors:  Daniel S Fierer; Douglas T Dieterich; Michael P Mullen; Andrea D Branch; Alison J Uriel; Damaris C Carriero; Wouter O van Seggelen; Rosanne M Hijdra; David G Cassagnol
Journal:  Clin Infect Dis       Date:  2013-12-13       Impact factor: 9.079

4.  Human immunodeficiency virus and hepatitis C virus coinfection in Nepal.

Authors:  Satish Prasad Barnawal; Surya Raj Niraula; Anand Kumar Agrahari; Nikesh Bista; Nilambar Jha; Paras Kumar Pokharel
Journal:  Indian J Gastroenterol       Date:  2014-03

5.  Impact of HIV infection in patients infected with chronic HCV (genotypes 1a and 3a): virological and clinical changes.

Authors:  Daryoush Behzadpour; Abbas Ahmadi Vasmehjani; Seyed Dawood Mousavi Nasab; Nayeb Ali Ahmadi; Rasoul Baharlou
Journal:  Pathog Glob Health       Date:  2016-11-10       Impact factor: 2.894

Review 6.  Treatment of Acute Hepatitis C Infection with Pegylated Interferon and Ribavirin in Patients Coinfected with Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis.

Authors:  Bing Zhang; Nghia H Nguyen; Brittany E Yee; Benjamin Yip; Walid S Ayoub; Glen A Lutchman; Mindie H Nguyen
Journal:  Intervirology       Date:  2015-09-25       Impact factor: 1.763

7.  Opportunities in proteomics to understand hepatitis C and HIV coinfection.

Authors:  Eric G Meissner; Anthony F Suffredini; Shyamasundaran Kottilil
Journal:  Future Virol       Date:  2012-08       Impact factor: 1.831

Review 8.  Virologic and immunologic aspects of HIV-hepatitis C virus coinfection.

Authors:  Kara W Chew; Debika Bhattacharya
Journal:  AIDS       Date:  2016-10-23       Impact factor: 4.177

Review 9.  Hepatitis C genotype 4: The past, present, and future.

Authors:  Tawhida Y Abdel-Ghaffar; Mostafa M Sira; Suzan El Naghi
Journal:  World J Hepatol       Date:  2015-12-08

10.  Impaired hepatitis C virus (HCV)-specific interferon-γ responses in individuals with HIV who acquire HCV infection: correlation with CD4(+) T-cell counts.

Authors:  Jacqueline K Flynn; Gregory J Dore; Gail Matthews; Margaret Hellard; Barbara Yeung; William D Rawlinson; Peter A White; John M Kaldor; Andrew R Lloyd; Rosemary A Ffrench
Journal:  J Infect Dis       Date:  2012-09-04       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.